glutathione cancer resistance A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung Human cancer-associated fibroblasts enhance glutathione
Human cancer associated fibroblasts enhance glutathione levels and antagonize drug induced prostate cancer cell death Cell Death & Disease glutathione metabolism in cancer progression and treatment resistance responsive nanomedicine leverages tumor redox imbalance for targeted glutathione cancer resistance Comparing total intracellular level (GSH + GSSG) in Role of Glutathione in Cancer Glutathione Dependent Pathways in Cancer Cells Overcoming resistance to cisplatin by inhibition of glutathione S transferases (GSTs) with ethacraplatin micelles in vitro and in vivo ScienceDirect
Pay in 4 interest-free payments of $6.96 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3




